LIZBETH GIBSON: Open Payments
NPI 1336591585 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 40 payments from 6 companies in 2025. Trend: 2023 $506 · 2024 $439 · 2025 $829
Food & beverage: $778Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $297 |
| ABBVIE INC. | 19 | $219 |
| Ardelyx, Inc. | 5 | $167 |
| Regeneron Healthcare Solutions, Inc. | 2 | $79 |
| Novo Nordisk Inc | 1 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
Products named: TREMFYA, IBSRELA, CREON, DUPIXENT, LINZESS, RINVOQ, ZENPEP, SKYRIZI.
Industry payments across CA — which companies pay providers there.
